Global Blood Therapeutics Investor Relations Material

Latest events

Investor Conference 2022

Global Blood Therapeutics

Q2 2022

8 Aug, 2022

Investor Conference 2022

10 Jun, 2022
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Global Blood Therapeutics, Inc. is a biopharmaceutical company that engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company focuses on acquiring rights to drugs and other products for which there is an unmet need in the treatment of SCD. The company is committed to delivering new, potentially transformative treatments for patients who have few options today.